Motamedi M, Haghighi L, Omidian M, Sarkari B. Coinfection of
Strongyloides stercoralis and
Aspergillus sp.
Interdiscip Perspect Infect Dis 2020;
2020:8649409. [PMID:
32565789 PMCID:
PMC7271055 DOI:
10.1155/2020/8649409]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 05/07/2020] [Accepted: 05/14/2020] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND
Strongyloides stercoralis has the ability to proliferate in its hosts for a long time. In most patients with a competent immune system, the infection remains asymptomatic.
OBJECTIVES
Herein, we report a case of concomitant infection of Strongyloides and Aspergillus. Similar cases reported previously were reviewed in the literature and discussed in terms of diagnosis, clinical presentation, and treatment.
METHODS
The patient was a 55-year-old man who had a medical history of two masses in his lung and was treated with corticosteroids six months before the presentation.
RESULTS
Using the parasitological methods, massive actively motile larvae of S. stercoralis were seen in the patient's faecal sample. Aspergillus infection was isolated from his fresh bronchoalveolar lavage (BAL) sample and confirmed by observing the septate, dichotomously branched hyphae in direct microscopic examination and also the isolation of the fungus from the culture medium. Molecular analysis revealed that the fungal species isolated from the patient are A. flavus and A. niger. Conclusion. The case highlights the features of concomitant infection of S. stercoralis and Aspergillus in immunocompromised patients and the importance of screening patients for strongyloidiasis before initiation of immunosuppressive therapy.
Collapse